Elon Musk has a problem with X’s Community Notes when he disapproves of the results
Elon Musk, CEO of Tesla and SpaceX and owner of social media platform X, speaks at the Conservative Political Action Conference at the Gaylord National Resort Hotel and Convention Center in Oxon Hill, Maryland, Feb. 20, 2025.
Andrew Harnik | Getty Images
For X owner Elon Musk, the solution to monitoring misinformation online has been the community, rather than a group of fact checkers. Since buying the social media company formerly known as Twitter in 2022, he’s touted the Community Notes feature as the best way to correct false posts.
That is, until he didn’t like the results.
Musk wrote in a post Thursday that he intends to “fix” Community Notes because it “is increasingly being gamed by governments & legacy media.” He provided no evidence to support his claim.
What apparently set Musk off was information members added in Community Notes correcting posts on X that claimed Volodymyr Zelenskyy, the country’s elected president, had low approval ratings among its citizens.
The Kyiv International Institute of Sociology, or KIIS, published survey results this week, based on February polling, that found that 57% of Ukrainians said they trusted Zelenskyy while 37% said they did not. The polling contradicted President Donald Trump’s claim that Zelenskyy is deeply unpopular in his country.
Tensions between the Trump administration, which includes Musk as a central figure, and the Ukrainian government have escalated over the past week, NBC News reported, before bubbling into public view.
Echoing Kremlin sentiments, Trump has accused Ukraine of starting a war with Russia that actually began when Russian President Vladimir Putin ordered his troops to invade the neighboring country in February 2022.
Senior White House officials met their Russian counterparts in Saudi Arabia on Feb. 18, with the aim of laying the groundwork for peace talks on Ukraine, while excluding Kyiv’s officials and EU representatives from participating in discussions.
Trump has called on Ukraine to hold new elections.
Zelenskyy said he would reject any plan that did not include Ukraine’s involvement. Under its constitution, Ukraine can’t hold elections while it’s at war and under martial law.
In his post Thursday, Musk wrote, “It should be utterly obvious that a Zelensky-controlled poll about his OWN approval is not credible!!” However, there are other available sources.
A consortium that’s been conducting extensive polling in Ukraine since 2014 found “63% of Ukrainians now approve of Zelensky’s performance as president, a notable increase from the previous year,” Joe Stafford, the news and media relations lead at the University of Manchester, wrote in a post Wednesday.
High favorability ratings for Zelenskyy undermine the narrative that Trump and Musk want to tell.
“If Zelensky was actually loved by the people of Ukraine, he would hold an election,” Musk wrote, again without evidence. “He knows he would lose in a landslide, despite having seized control of ALL Ukrainian media, so he canceled the election. In reality, he is despised by the people of Ukraine.”
First introduced by Twitter in 2021 as Birdwatch, and rebranded as Community Notes after Musk’s acquisition the following year, the feature was meant to help the social network combat misinformation and disinformation by enlisting users to flag misleading posts and provide correct information instead.
Community Notes has worked in a manner similar to Wikipedia. Facebook owner Meta, which has been aggressively seeking Trump’s favor in the early days of his second term in the White House, recently announced its own version of Community Notes. Alphabet’s YouTube has been testing a comparable tool since summer 2024.
Neil Johnson, a George Washington University physics professor who studies how misinformation and hate speech spread online, said the Community Notes model is problematic, but not because it can be gamed by large institutions. Rather, crowdsourcing is an inherently “imperfect system” for landing on the truth and is a poor substitute for “formal fact checking,” he said.
“Like any crowd, crowds can be fickle, and crowds can be driven by other interests,” Johnson said. “It’s not a paid person with the job of fact checking.”
Musk is not immune
Additionally, while Musk has pitched Community Notes as a way to replace fact checkers, a recent study by the Spanish fact-checking nonprofit Maldita showed that many X users still rely on information from professionals. The authors of the study, published earlier in February, looked at more than 1 million notes from Community Notes’ public dataset.
“The evidence from X clearly shows that users rely on the work of fact-checking organizations often” when proposing Community Notes, they wrote.
Neither Musk nor a representative from X responded to CNBC’s requests for comment.
Musk’s latest comments on Community Notes mark a sharp contrast to how he’s discussed the service in the past, and underscore the lengths to which he’s willing to go in pursuit of Trump’s agenda.
When talking about Community Notes in earlier posts, Musk has said that it can’t be manipulated by him or anyone else.
“The system is completely decentralized and open source, both code and data. Any manipulation would show up like a neon sore thumb!” Musk wrote in a post Dec. 30. “No one at X, including me, has any editorial control.”
Musk has also acknowledged in past posts that he is not immune from being corrected in Community Notes.
And Community Notes isn’t the only technology in Musk’s portfolio that could present problems by responding in ways he may not like. There’s also Grok, the artificial intelligence chatbot that is owned by Musk’s startup xAI and is used on X.
Fortune published a story in January about the many negative responses Grok provides when users ask if Musk is a good person. Grok’s reasons for saying he isn’t a good person include environmental hazards from SpaceX, Musk’s “erratic” management style and his political views, Fortune reported, citing Grok responses. Futurism published a similarly themed piece in December, with the headline “Elon Musk’s Grok AI blasts Elon Musk as huge spreader of misinformation.”
Musk calls Grok a “maximally truth-seeking” AI that is also “anti-woke.” Earlier this week, xAI introduced its latest AI model, Grok 3, claiming it can outperform offerings from OpenAI and China’s DeepSeek based on early testing, which included standardized tests on math, science and coding.
Musk did admit during the demo that the model isn’t perfect.
“We should emphasize that this is kind of a beta, meaning that you should expect some imperfections,” Musk said. “But we will improve it rapidly, almost every day.”
Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023.
Kelly Sullivan | Getty Images Entertainment | Getty Images
23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and Exchange Commission.
Wojcicki and New Mountain have offered to acquire all of 23andMe’s outstanding shares in cash for $2.53 per share, or an equity value of approximately $74.7 million. The company’s stock closed at $2.42 on Friday with a market cap of about $65 million.
The offer comes after a turbulent year for 23andMe, with the stock losing more than 80% of its value in 2024. In January, the company announced plans to explore strategic alternatives, which could include a sale of the company or its assets, a restructuring or a business combination.
23andMe has a special committee of independent directors in place to evaluate potential paths forward. The company appointed three new independent directors to its board in October after all seven of its previous directors abruptly resigned the prior month. The special committee has to approve Wojcicki and New Mountain’s proposal.
“We believe that our Proposal provides compelling value and immediate liquidity to the Company’s public stockholders,” Wojcicki and Matthew Holt, managing director and president of private equity at New Mountain, wrote in a letter to the special committee on Thursday.
Wojcicki previously submitted a proposal to take the company private for 40 cents per share in July, but it was rejected by the special committee, in part because the members said it lacked committed financing and did not provide a premium to the closing price at the time.
Wojcicki and New Mountain are willing to provide secured debt financing to fund 23andMe’s operations through the transaction’s closing, the filing said. New Mountain is based in New York and has $55 billion of assets under management, according to its website.
23andMe declined to comment.
WATCH: The rise and fall of 23andMe
Hims & Hers
Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved.
Semaglutide is the active ingredient in Novo Nordisk‘s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been prescribing compounded semaglutide as an alternative for patients who are navigating volatile supply hurdles and insurance obstacles.
Compounded drugs are custom-made alternatives to brand-name drugs designed to meet a specific patient’s needs, and compounders are allowed to produce them when brand-name treatments are in shortage. The FDA doesn’t review the safety and efficacy of compounded products.
Hims & Hers began offering compounded semaglutide to patients in May, and it owns compounding pharmacies that produce the medications.
Compounded medications are typically much cheaper than their branded counterparts. Hims & Hers sells compounded semaglutide for less than $200 per month, while Ozempic and Wegovy both cost around $1,000 per month without insurance.
The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days, depending on the type of facility, in order to “avoid unnecessary disruption to patient treatment.”
“Now that the FDA has determined the drug shortage for semaglutide has been resolved, we will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO Andrew Dudum posted Friday on X. “We’re also closely monitoring potential future shortages, as Novo Nordisk stated two weeks ago that it would continue to have ‘capacity limitations’ and ‘expected continued periodic supply constraints and related drug shortage notifications.'”
Him & Hers’ weight loss offerings have been a massive hit with investors. Shares of the company climbed more than 200% last year, and the stock is already up more than 100% this year despite Friday’s move.
Even before it added compounded GLP-1s to its portfolio, the company said in its 2023 fourth-quarter earnings call that it expects its weight loss program to bring in more than $100 million in revenue by the end of 2025.
Despite the turbulent regulatory landscape, Hims & Hers has showed no signs of slowing down.
On Friday, the company announced it has acquired a U.S.-based peptide facility that will “further verticalize the company’s long-term ability to deliver personalized medications.” Hims & Hers will explore advances across metabolic optimization, recovery science, biological resistances, cognitive performance and preventative health through the acquisition, the company said.
That move comes just days after Hims & Hers also bought Trybe Labs, the New Jersey-based at-home lab testing facility. Trybe Labs will allow Hims & Hers to perform at-home blood draws and more comprehensive pretreatment testing.
Hims & Hers did not disclose the terms of either deal.
Technology
Tesla recalls more than 375,000 vehicles in U.S. due to failing power-assisted steering systems
Tesla models Y and 3 are displayed at a Tesla dealership in Corte Madera, California, on Dec. 20, 2024.
Justin Sullivan | Getty Images
Tesla is voluntarily recalling 376,241vehicles in the U.S. to correct an issue with failing power-assisted steering systems, according to records posted to the website of the U.S. National Highway Traffic Safety Administration.
In a safety recall report posted on the NHTSA website, Tesla said the recall includes Model 3 and Model Y vehicles that were manufactured for sale in the U.S. from Feb. 28, 2023, to October 11, 2023, and that were equipped with a certain older software release.
The records said printed circuit boards in the steering systems in affected vehicles could become overstressed, causing the power-assist steering to fail in some cases when a Tesla vehicle rolled to a stop and then accelerated.
When electronic power-assist steering systems fail in a Tesla, drivers need to exert more force to steer their cars, which can increase the risk of a collision.
Tesla told the vehicle safety regulator that it was not aware of any crashes, injuries or deaths related to the power steering failures, and that it was offering an over-the-air software update as a remedy.
The recall follows an earlier related probe and voluntary recall in China concerning the same systems.
President Donald Trump has appointed Tesla CEO Elon Musk to lead a team that is slashing the federal government workforce, and in some cases, regulations and entire agencies. Those cuts already affected the NHTSA, an agency Musk has long seen as standing in the way of some of his ambitions at Tesla.
The regulator has been engaged in a yearslong investigation into safety defects in the systems that Tesla markets currently as its Autopilot and Full Self-Driving (Supervised) options. The features do not make Tesla cars into robotaxis. They require a human driver ready to steer or brake at any time.
The Washington Post reported on Thursday that Musk’s team has led mass firings at the NHTSA, reducing the agency’s workforce and capacity to investigate companies including Tesla by about 10%.
Tesla didn’t respond to a request for comment.
-
Sports2 years ago‘Storybook stuff’: Inside the night Bryce Harper sent the Phillies to the World Series
-
Sports11 months agoStory injured on diving stop, exits Red Sox game
-
Sports1 year agoGame 1 of WS least-watched in recorded history
-
Sports2 years agoMLB Rank 2023: Ranking baseball’s top 100 players
-
Sports3 years ago
Team Europe easily wins 4th straight Laver Cup
-
Environment2 years agoJapan and South Korea have a lot at stake in a free and open South China Sea
-
Environment2 years agoGame-changing Lectric XPedition launched as affordable electric cargo bike
-
Business2 years agoBank of England’s extraordinary response to government policy is almost unthinkable | Ed Conway